Skip to content

Author

Christopher M. Kramer

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

Decreases in Left Atrial Strain with Mavacamten Therapy and Associations with Atrial Fibrillation.

BACKGROUND In obstructive hypertrophic cardiomyopathy (oHCM), the cardiac myosin inhibitor (CMI) mavacamten improves left ventricular outflow tract (LVOT) obstruction and functional capacity. Symptoms and exertional capacity in oHCM are also influenced by left atrial function, commonly assessed by left atrial strain (L...

Myra Lewontin, Yaqub Betz, Kenneth C. Bilchick et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.